Sam Adams Says Hold My Beer — And You Are: Sales Numbers Dispute Cannabis Cannibalization Narrative
Sam Adams Says Hold My Beer — And You Are: Sales Numbers Dispute Cannabis Cannibalization Narrative
Sam Adams maker Boston Beer Co (NYSE:SAM) isn't seeing its cannabis-infused beverage segment tap revenue from its flagship lager.
山姆·亚当斯制造商波士顿啤酒公司（纽约证券交易所代码：SAM）没有看到其注入大麻的饮料板块从其旗舰啤酒中获得收入。
What Happened: The company disclosed its financial results for the first quarter, which ended on March 30. Its performance exceeded analyst expectations, too.
发生了什么：该公司披露了截至3月30日的第一季度财务业绩。其表现也超出了分析师的预期。
- The company reported a net revenue of $426.1 million
- That's more than 3.1% higher than analyst estimates of $413.21 million.
- Earnings per share (EPS) of $1.04 was above the analyst estimate for EPS of 9 cents.
- 该公司公布的净收入为4.261亿美元
- 这比分析师估计的4.1321亿美元高出3.1％以上。
- 每股收益（EPS）为1.04美元，高于分析师预期的每股收益9美分。
Sam Adams likely owes some of its success to the backlash Anheuser-Busch Inbev (NYSE:BUD) faced from conservative beer drinkers. The Bud Light parent company saw sales plummet on the heels of a promotional campaign with transgender influencer Dylan Mulvaney.
山姆·亚当斯的成功可能在一定程度上要归功于保守派啤酒饮用者对安海斯-布希英博（纽约证券交易所代码：BUD）的强烈反对。在跨性别网红迪伦·穆尔瓦尼开展促销活动之后，Bud Light母公司的销售额直线下降。
THC's so-called cannibalization of alcohol doesn't seem to resonate at Sam Adams, nor does it track at Tilray Brands Inc. (NASDAQ:TLRY). The Florida-based cannabis company, which purchased craft beer brands from AB Inbev, saw alcohol revenue spike 117% to $47 million.
四氢大麻酚所谓的自相残杀似乎没有引起山姆·亚当斯的共鸣，蒂尔雷品牌公司（纳斯达克股票代码：TLRY）也没有引起共鸣。这家总部位于佛罗里达州的大麻公司从百威英博收购了精酿啤酒品牌，其酒类收入激增了117％，达到4700万美元。
Why It Matters: Even before Boston Beer first entered the cannabis beverage market, industry analysts (i.e., Deloitte) predicted that alcohol and tobacco companies would utilize M&A or establish new product segments "to avoid losing market share to competing cannabis products."
为何重要：甚至在波士顿啤酒首次进入大麻饮料市场之前，行业分析师（即德勤）就预测，酒精和烟草公司将利用并购或建立新的产品细分市场，“以避免因竞争性大麻产品而失去市场份额”。
But, as it turns out, Boston Beer's customers are still enjoying Sam Adams in addition to new THC-infused items such as Teapot.
但是，事实证明，除了茶壶等注入四氢大麻酚的新产品外，波士顿啤酒的顾客仍然喜欢山姆·亚当斯。
Teapot, the 40-year-old company boasts, is Canada's premier cannabis tea brand. The company did not disclose THC beverage sales numbers in its most recent financial report.
这家拥有40年历史的公司自豪地说，Teapot是加拿大首屈一指的大麻茶品牌。该公司在最新的财务报告中没有透露四氢大麻酚饮料的销售数字。
"We saw a unique opportunity as consumer relationships with alcohol evolve, especially in a post-COVID world, where cannabis acceptance is on the rise. This convergence of trends led us to create cannabis-infused beverages," Paul Weaver, head of cannabis at Boston Beer, told Benzinga last year.
“随着消费者与酒精关系的发展，我们看到了一个难得的机会，尤其是在后COVID世界中，大麻的接受度正在上升。这种趋势的融合促使我们创造了注入大麻的饮料。” 波士顿啤酒大麻主管保罗·韦弗去年告诉本辛加。
Teapot is not listed among Boston Beer's so-called "core brands" (Sam Adams, Angry Orchard Hard Cider, Dogfish Head, Truly Hard Seltzer and Twisted Tea).
Teapot没有被列为波士顿啤酒所谓的 “核心品牌”（山姆·亚当斯、Angry Orchard Hard Cider、Dogfish Head、Truly Hard Seltzer和Twisted Tea）。
Boston Beer also backs Uncle Arnie's, a cannabis-infused beverage startup.
波士顿啤酒还支持注入大麻的饮料初创公司阿尼叔叔。
Other beer giants aren't bullish on the THC drink segment. Molson Coors Beverages Co. (NYSE:TAP), for example, exited a cannabis-related joint venture HEXO Corp. in 2022.
其他啤酒巨头并不看好四氢大麻酚饮料细分市场。莫尔森库尔斯饮料有限公司例如，纽约证券交易所代码：TAP）于2022年退出了一家与大麻相关的合资企业HEXO Corp.
Now Read: Boston Beer Exec Wants To Turn Time-Tested Liquor Logic Into Cannabis Retail Gold
立即阅读：波士顿啤酒高管希望将久经考验的白酒逻辑转化为大麻零售黄金
Image: Shutterstock
图片：Shutterstock